Development and user-testing of a brief decision aid for aspirin as a preventive approach alongside colorectal cancer screening

Abstract Background Several epidemiological and cohort studies suggest that regular low-dose aspirin use independently reduces the long-term incidence risk of colorectal cancer deaths by approximately 20%. However, there are also risks to use, mainly gastrointestinal bleeding haemorrhagic stroke. Making informed decisions depends on ability understand weigh up benefits available options. A decision aid support people consider therapy alongside participation in NHS bowel screening programme may have an additional impact prevention. This study aims develop user-test a brief about enable decision-making for screening-eligible members public. Methods We undertook qualitative leaflet responders deciding whether take reduce their cancer. The iterative development process involved two focus groups with public aged 60–74 years (n = 14) interviews clinicians 10). Interviews 11) were used evaluate its utility decision-making. Analysis was conducted using framework approach. Results Overall, participants found acceptable useful facilitate They expressed need individualised information, more detail potential aspirin, preferred information presented pictograms when offered different Implementation pathways discussed, including possibility involving such as GPs and/or community pharmacists. range potentially effective timepoints sending out identified . Conclusion An usable developed prevent